Nova Biomedical
Nova Biomedical is a company dedicated to using advanced technology to develop better blood testing analyzers for medical use. These products are called in vitro diagnostic devices (IVD). We use some of the same advanced technology to provide the biotechnology industry with innovative instruments for cell culture monitoring. Nova is the largest privately owned IVD company in the U.S. and the third largest in the world, with over 1,200 employees globally. Our eight percent compounded annual growth over nearly a decade is more than double the IVD market growth, making Nova one the fastest growing IVD companies in the world. Corporate Commitment to Quality: Nova’s size and rapid growth are the result of customers throughout the world responding to the exceptional quality and value of Nova’s technology, products, and customer service. Our strong corporate commitment to these three areas has made Nova a world leader in clinical, veterinary, and biotechnology chemistry testing analyzers.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About Us
Worldwide Market Areas Include:
Hospital Blood Gas and Critical Care Analyzers
Nova Biomedical is the world technology leader in the development of fast, whole blood analyzers to support the care of hospitalized and critically ill patients. Nova analyzers offer the most extensive stat test menus and deliver results in the shortest time at the lowest costs. Nova also provides handheld meter-and-strip based measuring systems for glucose, ketone, lactate, and creatinine point-of-care testing. Whether testing is performed in the central laboratory or in emergency, surgical, critical, or respiratory care areas, Nova analyzers can help to improve patient outcomes while reducing the cost of care.
Chemistry and Cell Culture Analyzers for Biotechnology
Nova manufactures a series of BioProfile® automated cell culture analyzers for rapid analysis of key nutrients, metabolites, pH, gases, and cell density/cell viability.
Self-Testing Diabetes Meters
Nova develops and manufactures blood glucose meters and test strips for self-testing by patients with diabetes. The glucose meters are distributed under the Nova Max® label in the U.S. and Canada, the Menarini label in Europe and the Walgreen's label in the U.S.
Product Development and Manufacturing for Corporate Partners
In addition to Nova products, we develop and manufacture medical devices and diagnostic products for many of the world’s leading healthcare corporations.
Pioneering Technological Innovations
Nova Biomedical has a 40-year history as the world leader in developing whole blood biosensors for clinical and cell culture/fermentation use.
A Global Company
Nova has sales and service operations in 100 countries through Nova subsidiaries or distributors. Nova’s wholly-owned subsidiaries are located in Brazil, Canada, France, Germany, the UK, Japan, Italy, the Netherlands, Spain, Switzerland, and the US, with distributors in 92 additional countries. Nova subsidiaries and distributors provide product information, demonstrations, local product inventory, and complete technical support. Whether you are located in North America, Europe, Russia, Eastern Europe, the Middle East, Africa, Asia, the Pacific Islands, Latin America, or the Indian Subcontinent, Nova can support your point-of-care and critical care testing needs. Nova’s global manufacturing operations take place in four facilities certified by the International Organization for Standardization (ISO) and are located in Waltham and Billerica, Massachusetts, USA and Taipei, Taiwan. These facilities occupy a total of 420,000 square feet (42,000 square meters) of manufacturing space.
Measurement Technologies Used by Nova Analyzers
Potentiometric (whole blood or plasma), Amperometric (whole blood/plasma or cell culture media), Conductivity (whole blood), Immunochemistry (whole blood or plasma), Spectrophotometric (plasma and cell culture media), Photometric (lysed whole blood), Ellipsometry (saliva/urine), and Imaging (cell culture)